Comprehensive medication guide to {drug} including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Cromolyn Sodium (brand name Gastrocrom) is a mast cell stabilizer used to treat systemic mastocytosis, mast cell activation syndrome (MCAS), and allergic conditions. It works by preventing mast cells from releasing inflammatory chemicals like histamine and leukotrienes. The oral solution is primarily prescribed for mastocytosis symptoms including diarrhea, flushing, headaches, abdominal pain, nausea, and itching. The nasal spray form (NasalCrom) is available over the counter for allergic rhinitis, and an ophthalmic solution treats allergic conjunctivitis.
Cromolyn Sodium stabilizes mast cells by preventing degranulation — the process where mast cells release inflammatory mediators like histamine and leukotrienes. Unlike antihistamines, which block histamine after it has already been released, Cromolyn prevents the release from happening in the first place. This makes it a preventive medication that must be taken consistently (typically 2–6 weeks) before full therapeutic benefit is seen. It has very low systemic absorption (0.5–2% bioavailability), meaning it acts primarily locally in the GI tract, nasal passages, or airways depending on the formulation.
Cromolyn Sodium oral solution has a findability score of just 30 out of 100, meaning it is very difficult to locate in stock at most pharmacies. An active FDA shortage that began in mid-2023 continues into 2026, driven by API sourcing difficulties, manufacturer exits (Woodward discontinued production), and NDC number changes causing pharmacy ordering confusion. Patients across 43+ states have reported being unable to fill their prescriptions. The nasal spray (NasalCrom) is more readily available OTC, but the oral solution remains scarce.
Struggling to find {drug} in stock? We'll call the pharmacies, sit on hold, and find you one that can fill your prescription.

Cromolyn Sodium oral solution is most commonly prescribed by allergists/immunologists and gastroenterologists, particularly for patients with mastocytosis or MCAS. Hematologists and oncologists may prescribe it for systemic mastocytosis, while pulmonologists historically prescribed the inhaled form for asthma (now largely discontinued). Primary care physicians and internists can also prescribe Cromolyn. The nasal spray (NasalCrom) is available OTC and does not require a prescription. Telehealth consultations are available for obtaining prescriptions.
No, Cromolyn Sodium is not a controlled substance and has no DEA scheduling. It has no potential for abuse or dependence. The oral solution requires a prescription, but the nasal spray (NasalCrom) is available over the counter without a prescription.
Serious but rare side effects include severe allergic reaction (anaphylaxis), worsening of symptoms, joint pain and swelling, and difficulty swallowing. Contact your doctor immediately if you experience any serious side effects.
Cromolyn Sodium remains an essential medication for patients with mastocytosis and MCAS, but the ongoing shortage that began in 2023 continues to make it very difficult to find in 2026. With a findability score of just 30/100, patients should plan ahead, check multiple pharmacies, and consider alternatives like compounded versions or substitutes such as Ketotifen when Cromolyn is unavailable. Using tools like Medfinder can help locate pharmacies that currently have Cromolyn in stock without the frustration of calling around. If you are struggling to afford Cromolyn, patient assistance programs like Prescription Hope ($70/month) and discount cards from GoodRx can significantly reduce costs.